Group items tagged

Our Totton branch has an incredibly high volume of original pack dispensing, roughly 45,000 items. As we became busier and busier in the dispensary we were finding that our pharmacists, dispensers and other technicians simply didn't have capacity to deliver the services that we needed them to. We all know there is a real emphasis right now on pharmacies doing more services and we knew we had to change the way we operate to survive. So we decided it was time to look into a sound automation solution for our medication dispensing process, one that would allow us to free up the time of the pharmacists and the rest of the team so they could better support patients. After a lot of research we invested in Centred Solutions FLOWRx Hub and InStore solutions which were installed late last year. It provides us with the whole package and has automated our entire dispensing process from picking to packing and labeling to checking. Our situation was quite unique as we bought the system initially for our existing high-volume pharmacy in Totton so the hub and the spoke are actually on the same site. People wouldn't usually look at a hub and spoke solution for that kind of set up but it has allowed us to significantly free up time in store for more services. What it has also done is allow us to look at other opportunities to grow and expand. The pharmacy landscape is changing and there are lots of opportunities coming up. We have found that having your technology and the right infrastructure in place to support your existing footprint before you expand is the ideal way to grow in a safe and controlled way. We never thought that five years ago we would buy another pharmacy, yet we have already bought one and are now in the process of buying two more. I'm not worried about the increase in volume this expansion will bring because I know our technology is going to be able to support it. The pharmacies we are buying are struggling but having our solution already in place m

In ayurveda, we have some basic rules for quality life one of such rule is "If your GIT ( Gastero intestinal Tract ) is good you can enjoy good life". It was told by our grandparents to eat only when you feel hungry and eat according to your stomach. Always, eat less then what you want because totally filling your stomach with food can cause improper digestion of food when these improper digested food particles circulate in our body they cause disease. But we in modern lifestyle act totally against these rules. We eat whenever we want without any hunger. When are at home, we eat breakfast, lunch , dinner then we go for shopping we eat burger or chat papri etc., we go to someone's house we eat biscuits and drink tea or cold drinks. We never give rest to our stomach. Food is first pillar of Quality life. It act as fuel of our body. But what will happen if we have food but improper functioning system(GIT) to digest or use this fuel. GIT is a type of pipe where food is chewed in small particles in mouth then digested in stomach, energy from food is absorbed from intestine, waste particle is stored in rectum to excrete after proper interval. Food takes its specified time in each part of GIT. But what will happen if this specified time become shorter. Then you will feel colic pain stomach which relieve after defecation. You feel urge to defecate 30 mins to 1 hour after meal. You start thinking thrice before eating any food. This type of disease is called Irritable Bowel Syndrome (IBS). Dr. Satinder is Ayurvedic doctor in ambala having years of experience in this field. He has helped many patients during these years. He will not only help you in coming out of such problems but will help you mentally to live a healthy life.

In ayurveda, we have some basic rules for quality life one of such rule is "If your GIT ( Gastero intestinal Tract ) is good you can enjoy good life". It was told by our grandparents to eat only when you feel hungry and eat according to your stomach. Always, eat less then what you want because totally filling your stomach with food can cause improper digestion of food when these improper digested food particles circulate in our body they cause disease.

Today I'm proud to share with you the statement we submitted to the UK Commission on Pharmacy Professional Leadership in which we set out what professional leadership means to RPS. I recognise we haven't always been clear in communicating our ideas to members and our external stakeholders. Through the Commission, and our own Independent Review of member participation and communications, we are determined to remedy this. We're committed to lead pharmacy in the best interest of patients and the professions. This means that sometimes we will need to take difficult decisions. We will do the right thing for the long term, ultimately driving what's best for patient care. There are some key changes we believe are necessary to fulfil the profession's ambitions. To achieve a more unified approach to pharmacy leadership, we believe both pharmacists and pharmacy technicians should be represented by RPS within professional faculties that capitalise on the strengths of each discipline whilst retaining distinct professional voices. Many of our members work with pharmacy technicians every day and know just how essential they are to their role and to patient care. We feel the same at RPS and it makes perfect sense to evolve into an organisation where both professions can advance their scope of practice, working in alignment as part of the wider multi-professional team. We will develop and implement post-registration curricula and credentialing for all pharmacists and pharmacy technicians working with patients and the public. To do this we will require formal delegation of authority by the GPhC.

As we take look back over the past year and reflect on what we have achieved, it's also important that we look ahead to new challenges and opportunities that may arise in 2023. We have seen remarkable innovation across the industry in 2022, from big break throughs in treatment and improvements to patient outcomes, to how the industry is working with big data and technology. But it's fair to say that these achievements came paired with just as many challenges including a continued talent shortage, hangovers from the pandemic, increasing pressures to innovate and ongoing macroeconomic challenges. As we head into 2023, I expect these existing challenges to continue alongside new ones, but I also anticipate more opportunities to present themselves. At Pharamanovia, we predict that the key trends set to catalyse the pharmaceutical and healthcare industries in 2023 include break through innovations, technology, big data, sustainability, ongoing policy changes and a shift in investment due to inflation. Utilising big data and tech Technology has been recognised as one of the industry's biggest tools for many years, and I don't expect to see the pace of how we use technology in healthcare and pharma to slow down any time soon. In 2023, I expect that we will see further automation in the way we work, with an increase in digital engagement and healthcare providers leveraging remote access further.

Despite being relatively new to the dispensing doctor market as a short-liner, Bestway Medhub is seeing exponential growth in the market in addition to the 3,500 independent pharmacies that we service and deliver to. We have however been servicing the dispensing doctor market for well over 40 years through our dispensing appliance contractor (DAC) Wardles. Wardles service and supply more than 55% of all dispensing sites with dressings, bandages, appliances, ostomy, wound care and hosiery. Graham Burford-Row To meet the needs of dispensing practices and surgeries we carry a large range of more than 10,000 Generics, PI's and OTC products. We offer net pricing so the practice can see straight away what price they are paying for their products - with no hidden fees. We offer all our practices 24-hour online ordering via our Bestway Medhub ordering portal and our recently launched Wardles FP Portal. Additionally, we have the backup of a telesales department with personal service from myself and a dedicated Internal Dispensing Dr Account Manager. We offer daily, weekly or monthly calls to those customers wishing to hear our special offers. Our deliveries are done daily via our third party full-line logistics partner for efficient deliveries, which no other short-line wholesaler offers. Bestway Medhub understands that dispensing practices are not only in the business of offering superior care to their patients and community, but they also offer numerous other services like clinics, nursing and referrals. By enabling practices to cost save, the funds could be used elsewhere instead.

Because apparently having small breasts in 2017 is good, we tell you a "true or false" on the received ideas that can be read on the web about it. En route for a short journey between myth and reality..!! For years we had been labelled with "true truths" concerning small breasts, as if those who had a more luscious feel felt obliged to tell us the painfulness of the thing, as to make us accept our "sad fate. " But since 2015, a new wind blows favour of the caps A and B! The modest-sized breasts have become beautiful, sensual in the eyes of others and we can finally be proud of what we have under the t-shirt. Gone are the "Wonderbra" and other "push-ups" stuffed, we decomplex, we stop dreaming of compensated tits and we break in 10 points the most prevalent prejudices on the subject!

Side Wheel Attachment for removably attaching an auxiliary side wheel to a cycle or bike. The side wheel attachment comprises a single structural rod which is folded in the desired shape, i.e. forms a helical torsion spring. In natural unbiased condition, the first and second ends of the spring rod extend generally perpendicularly to one another. The first end of the spring is inversely U-shaped and tangentially engages by its web the rear axle of the cycle or bike where it can be fixed after adjusting its vertical position relative to the cycle or bike. These attachment are useful for Handicap's vehicle. You can also get other equipment like Three Wheeler, Tricycle and modified Vehicle as per your convenient.We provide a wide range of side wheel attachment, which are can be attached with different kinds of two wheelers. These side wheel attachment are available in different sizes, designs, colors & other technical specifications. Our range of products are highly demanded by our clients due to their features & quality. Moreover, these products are available at reasonable prices.Providing best and sophisticated equipment for Handicapped like Three Wheeler, Side Wheel Attachment, Vehicle and Tricycle etc. features: Excellent Output High quality raw material Easy to use This Three Wheeler is easy in function and easy to maintain.We provide a specially designed handicapped Three Wheeler to disable people. To have an easy life we provide scooter or bike with wheels to those who likes to live like normal people. We provide a quality range of products which are made up of grade raw material and technologies. We test our products before dispatching them so that the products don't create any type of problem. Battery operated three wheeler for handicapped are also provided by our company so that they can charge it in their house easily.The mobility three wheeler products that we offer are not just mobility assistance but also indeed the much needed confid

Velpanat 400Mg Suppliers Price India, , we are leading suppliers and exporters of velpanat 400mg (Velpatasvir and Sofosbuvir) tablets in China, Russia, Hongkong, India. Modern times medicine provide the best price on Velpanat 400 Mg tablet which you can- not buy from other venders. As a leading suppliers we ensure our customers that we are commited to on-time deliverly of the product that you buy from us. We are leading suppliers & exporters of "Velpanat 400Mg" in China, Russia, Hongkong, Bulgaria, Romania, India, Uk, USA. We're largest suppliers of Natco medicines & provide you the best price on Velpanat. The lowest price sellers, suppliers, distributors & Exporters from Delhi. For more info please contact us. Online Velpanat 400Mg tablet suppliers in India Velpanat 400Mg Suppliers India, Velpanat 400Mg Suppliers Russia, Velpanat tablet is a fixed-dose combination tablet containing sofosbuvir and velpatasvir for oral administration which are direct-acting antiviral agents against the hepatits C virus. Sofosbuvir is a nucleotide analog HCV NS5B polymerase inhibitor and velpatasvir is an NS5A inhibitor. Velpanat-tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir 100mg each tablets. the each tablet of it include the following inactive ingredients:copovidone, croscarmellose sodium, magnesium stearate, and microcrystalline cellulose. Film coated of velpanat medicine each tablet- sofosbuvir 400 mg and ledipasvir 90 mg with a coating material containing the following inactive ingredients: Titanium Dioxide IP and Brilliant blue FCF, polyethylene glycol, polyvinyl alcohol and titanium dioxide. The effect of sofosbuvir 400 mg (recommended dosage) and 1200 mg (three times the recommended dosage) on QTc interval was evaluted in an active-controlled (moxifloxacin 400 mg) thorough QT trial. Buy Online Suppliers price of Velpanat 400Mg India Details of velpanat tablet- Brand name - Velpanat Tablets Generic of medicine - Velpatasvir and Sofsob

As we transition in England through yet another NHS organisational change, I ask myself what does this mean for community pharmacy? I would like to think that this change will bring about opportunity and a chance for community pharmacy to showcase and continue the excellent work that was carried out during the height of the pandemic and is still ongoing today. I hope that it allows community pharmacy to be regarded as part of the NHS rather than sitting on the side lines. This change has to lead to better funding for community pharmacy, without sufficient funding we will see more pharmacies close. We are hearing a lot about winter pressures but this year it feels like all year round pressure. What I have seen, whilst the NHS is under such pressure, is North East London (NEL) CCG transitioning to an integrated care board (ICB) almost seamlessly. I have seen people transitioning into new roles, whilst working hard to ensure that all plates are still spinning, which at the moment is no mean feat. I spent a day out recently visiting pharmacies with the chief medical officer of NHS NEL, Dr Paul Gilluley. The visits were positive, we felt listened to and understood. The feedback was great, it was recognised that community pharmacy is often the informal front door to the NHS and that we have so much to offer in terms of ill health prevention. Community pharmacy can offer a total solution as long as we have the tools to do so, which can save so much time and money. An example is the GP CPCS service, which has launched well across NEL.

Medicines and Healthcare products Regulatory Agency (MHRA) has urged the healthcare professionals to share their views on the consultation on 'how MHRA communicate with healthcare professionals to improve medicines and medical devices' safety'. Through this consultation the agency wants to review its approach to engagement with healthcare professionals to improve the safety of medicines and medical devices. "We want to ensure that healthcare professionals are receiving actionable information and guidance on safe use of medicines and medical devices that they can take into their working practice, providing timely advice to patients," said MHRA. "We need to improve the way we communicate with healthcare professionals. We want to hear from you to enable us to transform how we communicate with you and how we work together on our common goal of greater patient safety."

Advanced technology is its flexibility. wheelchair provide some technologies can be used at home like power wheelchair,hearing aids,moped in the workplace, and in school, expanding the ability of the user to participate in various spheres of daily life. Augmentative and alternative communication technology is one such area of IT progress.where we use of hearing aids for communication and It includes inventions such as speech-generating devices, Teletypewriter devices, adaptive pointing devices to replace computer mouse devices, and many others. The following impairments are some of the disabilities that affect communications and technology access, as well as many other life activities: communication disorders: hearing impairments: visual impairments: mobility impairments: a learning disability or impairment in mental functioning. Each kind of disability requires a different kind of accommodation like dumb person use hearing aids and this may require analysis by a medical specialist and in medical,hospital we can see that disable person use health care product, an educational specialist or a job analysis when the impairment requires accommodation. Assistive technology is the creation of a new device that assists a person in completing a task that would otherwise be impossible,we take some example if some one not walk but now days they can do by use of power wheelchair,basic wheelchair,commode wheelchair. Some examples include new computer software programs, and inventions such as assistive listening devices, including hearing aids, and traffic lights with a standard color code that enables colorblind individuals to understand the correct signal,mode also useful for wondering in one way to another way. now we talk about adaptive technology so adaptive technology is the adaptation,modification, of existing devices, methods, or the creation of new uses for existing devices, to enable a person to complete a task. Examples include the use of remote control

The Internet has become an integral part of all of our lives. We use it to do our work, connect with people and gain knowledge about various subjects. As our representatives, many of you use it to gather research about the issues faced by your constituents, the challenges faced by different parts of our country, and the expert knowledge needed to legislate for India's future and shape our national decisions. Today, the Internet in our country is facing the danger of losing its neutrality, which is vital to ensure that it grows to reach many more of our fellow Indians - and the people who use it innovate further. In the interest of furthering this cause, we have launched a campaign with fellow Indians who wish to 'Save the Internet'. This letter is addressed to Parliamentarians who have already taken or are considering taking a position on the recent consultation paper released by the TRAI for Internet licensing and net neutrality. We are grateful for the support we have received and the various public statements made by several of you which cut across party lines. Through this letter we wish to point out the intent and purpose of saveinternet.wheelchairindia.com campaign and also the call for a larger network neutrality law in India.

One day, a prof entered the room and declared a surprise test. Hearing this, all students got anxious and commenced considering what would come back up within the test. The prof distributed the question paper, with the front side facing down. when turning in the papers to all the students, he asked them to turn the page and begin the test. To everyone's surprise, there have been no questions within the test paper. There was simply a black dot within the center of the page. everybody was surprised and checked out the prof in awe. The prof told the students: "I need you to write a few lines regarding what you see on the paper." All the scholars were stupefied however since they didn't have a alternative, they started writing the solution. Once everybody was through with the test, the prof collected all the solution sheets, and commenced reading out every answer aloud before of the full class. without an exception, all the scholars had written regarding the black dot, mentioning regarding its position, size etc. when reading out all the answers, the prof addressed the scholars and told them: "None of you'll be ranked on this test. I simply needed you to ponder over one thing. All of you wrote regarding the black dot. nobody wrote regarding the white part of the paper. a similar issue happens in our lives too. we tend to all have a white paper to watch and learn from, nevertheless we tend to continually target the dark spots. we've got so many reasons to celebrate - our folks, co-workers, friends, good health, a satisfactory job, a child's smile, the miracles we tend to witness daily, and so on. However, we tend to merely limit our horizons by focusing on simply the dark spots - our disappointments, our frustrations, our fears and anxieties, things that hassle us, those that wronged us, etc. In our daily lives, we tend to take such a lot of good things with no consideration, and focus our energy on insignificant dot-like failures and disappointments." Though

Pirfenex 200Mg Tablets Suppliers India, Pirfenex® is a famous product on international market for pirfenidone, an oral medication used for the treatment of idiopathic pulmonary fibrosis (IPF). Each pack coated tablet pirfenidone 200 Mg. We are leading suppliers & exporters of "Pirfenex 200 Mg Cipla Pirfenidone Tablet" in China, Russia, Hongkong, Bulgaria, Romania, India. As we are a largest suppliers and exporters of Cipla medicines & provide you the best price on Pirfenex 200 Mg Cipla Pirfenidone Tablet. The lowest price Sellers, Suppliers, Distributors & Exporters from Delhi. For more info please contact Us. Buy Online Pirfenex 200Mg Cipla Pirfenidone Tablet in Russia-China-India Pirfenex tablets suppliers India Pirfenex 200Mg Pirfenex200 Mg Cipla Pirfenidone Tablet include chemical salt Pirfenidone 200 Mg. Pirfenex comes in 200 Mg Stength. Pirfenex available in 30 tablets pack. Pirfenex is manufactured by Cipla. Of these, the bleomycin model is the most widely used model of pulmonary fibrosis. Medicine Detail: Brand Name: Pirfenex Chemical salt: Pirfenidone Strength: 200 mg Packing: 30 Tablets Form: Tablet Manufactured: Cipla Ltd Pirfenex200mg Pirfenidone Tablet is an antifibrotic agent and used to treat gentle cases of a lung disease namely idiopathic pulmonary fibrosis. While the exact working of this medication is not known. On utilizing this medication you will expertise aspect effects like muscle pain, sneezing, dizziness, reduced craving, sharp weight loss, issue with sleeping, heartburn, acidity, amendment in style, weakness, fatigue, headache, runny nose, indigestion, diarrhea, nausea, vomiting, rash and redness. If you face any hypersensitivity or adverse reactions request the assistance of your health care supplier directly. Before using this drug give notice to your doctor if: you're allergic to any of the ingredients contained at intervals Pirfenex200mg tablets, you've got liver /kidney issues, you've got the other allergies,

We are not trying to create any hoax, nor do we intend to create any hype for no reason! A report by Australia's Breakthrough National Centre for Climate Restoration (BNCCR) claims that we have just another 31 years after which the climate change will cause more than 90 percent of humans to wipe out. So, if we do not mend our ways in harming the climate, by 2050, the human race will cease to exist!

Palbace 125 Mg Capsules Suppliers-exporters India , Palbace a 125Mg Capsule is employed within the treatment of carcinoma. It's additionally wont to treat patients with bound varieties of carcinoma (estrogen receptor-positive, human stratum protein receptor 2-negative) that have unfold to alternative organs. it's given in conjunction with secretion malignant tumor therapies. We are leading suppliers & exporters of "Palbace 125Mg" in China, Russia, Hongkong, Bulgaria, Romania, India. We're largest suppliers of Pfizer India medicines & provide you the best price on Palbace 125Mg. The lowest price sellers, suppliers, distributors & Exporters from Delhi. For more info please contact us. Buy Online Palbace 125Mg Suppliers Price India Palbace 125Mg suppliers India Palbace 125mg Capsules Palbace (known as IBRANCE in other parts of the world) or palbociclib by Pfizer is a cancer drug that interferes with the growth and spread of cancer cells in the body. Description Brand Name: Palbace Generic Name: Palbociclib Strength: 125mg Packing: 21 Capsules in a bottle Form: Tablets Palbace125Mg is generally used in combination with letrozole or fulvestrant (Faslodex) for treating certain types of advanced breast cancer in postmenopausal women. It is also given in combination with another cancer medicine, either letrozole (Femara) or fulvestrant (Faslodex). Palbace is a renamed version of the drug Ibrance for the Indian market. It is verified by the US Food and Drug Administration (FDA). In clinical studies, palbociclib appeared to increase survival time of patients. Palbace comes in capsule form in 125 mg dose. 1 pack has 21 capsules. How Palbace125Mg capsules works ? Palbace 125mg capsule is an anti-cancer medication. It works by busy bodied with a enzyme, a sort of supermolecule within the body that helps management biological process. This stops cancer cells from dividing and growing. It is additionally won't to treat patients with bound kinds of carc

Presently, In the US, around 12% of women develop breast cancer over the course of their lifetime. In Canada, an estimated 26,900 women were expected to be diagnosed with breast cancer in 2019 and breast cancer accounts for nearly 25% of new cases of cancer among Canadian women. Download complete report summary @ http://bit.ly/2vsEa1D

Deep Dental Clinic is now also providing Permanent MakeUp & Facial Aesthetics in Chandigarh. Now we are partner with Timeless Aesthetics, which is well known name in the this industry. As we now that we all are somewhere conscious about our looks, There are so many people who just lost their confidence due to so many reasons. We help people in fixing their facial scars and help those who lost their hair due to cancer or trauma. We provide a permanent makeup & facial aesthetics to your problems.

The National Pharmacy Association (NPA) is calling on NHS England and its member to pause and reflect before further implementing the pharmacy contraception service. NPA board met on Tuesday (25 April) to discuss the Pharmacy Contraception Service and the board decided that - with the community pharmacy sector at breaking point - it cannot support the immediate roll out of this service. The association believes that with no new funding for the service, and all existing funds in effect already allocated to other pharmacy activity, any payments to the sector for delivery of the oral contraception service will ultimately be clawed back by NHS England. Tweeting after the meeting yesterday, the NPA said: "We can't tell pharmacy owners what they can and can't do. But we can tell them the facts; fact number one is that with no new funding currently available everyone will be a loser from the implementation of this service on the current terms." NPA Vice-Chair Jay Badenhorst added: "We cannot be expected to take on more and more services without the increase in funding necessary to deliver them effectively. Meanwhile, taking on additional work when current workload already exceeds capacity risks impacting negatively on the overall quality of care people experience in pharmacies. We still believe this could, in future, be a great new pharmacy service, but not without the extra funding necessary to deliver it safely and effectively. We want to offer women this extra support, but if it's worth doing it's worth doing properly."

AmerisourceBergen, a leading pharmaceutical solutions organisation announced its intent to change its name to 'Cencora' to better reflect its bold vision and purpose-driven approach to creating healthier futures. Steven H. Collis, Chairman, President & Chief Executive Officer of AmerisourceBergen said: "Over time, we have established ourselves as a trusted industry partner that prioritizes innovation, advocates for patient access and advances strategic partnerships across the global pharmaceutical supply chain. To further bolster our position, we must continue to adapt and evolve within our dynamic industry as we pursue the goal of enhancing health outcomes. Building a unified brand is fundamental to our identity as a global healthcare company. We believe our new name better reflects who we are today and our impact across pharmaceutical care." AmerisourceBergen intends to begin operating as Cencora in the second half of calendar year 2023. The change to Cencora is aligned with the organisation's growth strategy and continued emphasis on innovation. AmerisourceBergen has focused on supporting pharmaceutical advancement and access for patients, manufacturers, and providers across the global healthcare supply chain.

Panadol launched a new purpose-led brand idea as part of a multi-channel campaign across Great Britain and Ireland. With nine out of 10 people suffering "everyday pain" and 65% of people saying they can't be happy when they are in pain[1], globally, the campaign reiterates the brand's commitment to holistic pain management by focusing on the acute pain recovery journey. Rooted in deep consumer understanding, the campaign idea celebrates that never-talked-about moment of realisation when you start to feel the release from pain. The new brand idea will bring to life the emotional transformation that those suffering from acute pain undergo, emphasising the role that Panadol can play in alleviating their pain. The Panadol campaign follows a period of strong sales growth for the brand, outperforming the category's own expansion by more than double[2]. This has been driven by shoppers who are searching for fast and effective pain relief products, such as Panadol's hero variants, including Panadol Extra Advance Tablets (paracetamol, caffeine), which has seen its growth almost doubled[3], as well as Panadol Advance Tablets (paracetamol) and Panadol Extra Advance Tablets. Monica Michalopoulou, GBI Marketing Director, said: "After two years of pandemic restrictions, now more than ever, people want to get back to their normal lives and to the people they love. But with pain preventing many of us from connecting with those we love or from doing the things we enjoy the most, we want to help consumers by understanding their pain journey and reassuring them on the treatments we can provide. This "Release" moment is so important for pain sufferers, and we hope our new brand campaign can shine a light on the role that Panadol can play in pain relief".